Obesity is not only a risk factor for developing knee and hip arthritis. It is also linked to less favorable outcomes after joint replacement surgery. Two new studies at Hospital for Special Surgery (HSS) in New York City find that bariatric surgery prior to joint replacement is a cost-effective option to improve outcomes after hip or knee replacement.
The research was presented at the annual meeting of the American Academy of Orthopaedic Surgeons in Las Vegas. One HSS study looks at the costs and benefits of weight-loss surgery prior to knee replacement, and the other analyzes the costs and benefits before hip replacement.
"Up to 50 percent of hip replacements are performed in obese patients at some institutions," said Emily Dodwell, MD, an orthopedic surgeon at HSS and lead investigator. "Obesity is associated with longer hospital stays, higher overall costs and higher failure rates, necessitating costly revision surgery."
It is well-known that obesity takes a toll on one's health. Bariatric surgery and subsequent weight loss reduces the risk of heart disease, diabetes and even some forms of cancer. But the effect of bariatric surgery on joint replacement outcomes was not known, and this is what HSS investigators set out to determine.
"We know that bariatric surgery is a cost-effective intervention for morbid obesity," said Alexander McLawhorn, MD, a chief orthopedic surgery resident at HSS and study author. "Yet, the cost-effectiveness of bariatric surgery to achieve weight loss prior to joint replacement and thus decrease the associated complications and costs in morbidly obese patients was unknown."
Investigators used a sophisticated computer software program to compare the cost-utility of two treatment protocols for patients who were considered morbidly obese and had advanced knee or hip osteoarthritis. One group had joint replacement immediately, without losing weight. The other group had bariatric surgery, followed by hip or knee replacement two years later. Patients typically lose weight during this time period.
"For the study, we chose a decision analysis design because we could use a mathematical model to simulate the outcomes and costs of each treatment path based on results and costs that have already been published in the literature," Dr. Dodwell explained.
Study patients had a BMI of at least 40, or a BMI of 35 or higher and at least one other serious obesity-related health problem. Normal BMI is 18.5 to 24.9. For study purposes, researchers assumed that at least one-third of patients having bariatric surgery lost their excess weight prior to undergoing joint replacement.
"Our findings indicate that surgical weight loss prior to joint replacement is likely a cost-effective option from a public payer standpoint in order to improve outcomes in obese patients who are candidates for joint replacement," Dr. Dodwell said. "Some health care systems do not include weight loss surgery as a covered benefit, and it is possible that studies such as this will be helpful in re-evaluating whether weight loss surgery may be a reasonable covered benefit."
Dr. McLawhorn notes that for some patients experiencing severe knee or hip pain, it may be impractical to hold off on joint replacement. He adds that many times, an orthopedic surgeon is the first doctor such a patient sees for arthritis pain.
"Ideally, a team approach would be used to treat morbidly obese patients with hip and knee arthritis in which various health care professionals are in place to help a patient lose weight, improve his or her health, and optimize nutrition before joint replacement to maximize its benefits," he said.
American Academy of Orthopaedic Surgeons Annual Meeting
Study Title: Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese
Presentation Number: Paper 669
Session: 661-675-Adult Reconstruction Knee VI
Date: March 26, 4 PM - 6 PM
Location: Venetian Ballroom D
Authors: Alexander S. McLawhorn, MD, MBA, New York, New York (HSS)
Daniel L. Southren, BA, Suffern, New York (Columbia University College of Physicians and Surgeons)
Claire Wang, MD, PhD, New York, New York (Columbia University)
Robert G. Marx, MD, New York, New York (HSS)
Emily Dodwell, MD, New York, New York (HSS)
Study Title: Cost-Effectiveness of Bariatric Surgery Prior to Total Hip Arthroplasty in Morbidly Obese Patients
Presentation Number: Poster 078
Session: P001-P105-Adult Reconstruction Hip Posters
Date/Time: Tuesday, March 24th, 7 AM - 3 PM
Location: Academy Hall G
Authors: Daniel L. Southren, BA, Suffern, New York (Columbia University College of Physicians and Surgeons)
Alexander S. McLawhorn, MD, MBA, New York, New York (HSS)
Mark P. Figgie, MD, New York, New York (HSS)
Emily Dodwell, MD, New York, New York (HSS)
About Hospital for Special Surgery
Founded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics, No. 3 in rheumatology and No. 7 in geriatrics by U.S.News & World Report (2014-15), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center three consecutive times. HSS has one of the lowest infection rates in the country. HSS is a member of the New York-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at http://www.